![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Advaite Gets FDA Emergency Use Clearance for 15-Minute COVID-19 Test
Advaite Gets FDA Emergency Use Clearance for 15-Minute COVID-19 Test
![15 minutes COVID-19 Test](https://www.fdanews.com/ext/resources/test/Device_Images6/15-minute-COVID-19-test.gif?t=1585659244&width=430)
January 13, 2021
Advaite has been handed Emergency Use Authorization from the FDA for RapCov, a rapid IgG antibody test for COVID-19.
The serology test uses a single drop of fingertip blood to detect IgG antibodies to the virus in 15 minutes in point-of-care settings, meaning it does not require any offsite lab work.
The Malvern, Pa.-based diagnostics maker said that it intends to immediately begin supplying the U.S. market with the test kit on a national scale but did not say how much the test will cost.
Upcoming Events
-
21Oct